These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6336454)

  • 21. CYP2C9 variant modifies blood pressure-lowering response to losartan in Type 1 diabetic patients with nephropathy.
    Lajer M; Tarnow L; Andersen S; Parving HH
    Diabet Med; 2007 Mar; 24(3):323-5. PubMed ID: 17305793
    [No Abstract]   [Full Text] [Related]  

  • 22. Intervention in nephropathy due to insulin-dependent diabetes mellitus (IDDM).
    Stephen RL; Maxwell JG; Harrow JJ; Jacobsen SC; Hanover BK
    Kidney Int Suppl; 1985 Dec; 17():S60-5. PubMed ID: 3867801
    [No Abstract]   [Full Text] [Related]  

  • 23. [Angiotensin-converting enzyme inhibitors in the treatment of diabetic nephropathy].
    Sawicki PT; Mühlhäuser I; Berger M
    Dtsch Med Wochenschr; 1994 Sep; 119(38):1298-9. PubMed ID: 7924925
    [No Abstract]   [Full Text] [Related]  

  • 24. Diabetic nephropathy and beta-cell replacement therapy.
    de Fijter JW
    Neth J Med; 2004 Mar; 62(3):71-5. PubMed ID: 15209470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probability of retaining endocrine function (insulin independence) after definitive loss of exocrine function in bladder-drained pancreas transplants.
    Barrou B; Barrou Z; Gruessner A; Munns KC; Gruessner RW; Sutherland DE
    Transplant Proc; 1994 Apr; 26(2):473-4. PubMed ID: 8171511
    [No Abstract]   [Full Text] [Related]  

  • 26. [Diabetic nephropathy - Diagnostic].
    Hader C; Plum J
    Dtsch Med Wochenschr; 2002 Jun; 127(24):1324-7. PubMed ID: 12063665
    [No Abstract]   [Full Text] [Related]  

  • 27. [Transplantation of pancreas and kidney in diabetic nephropathy (author's transl)].
    Largiadèr F; Baumgartner D; Uhlschmid G; Binswanger U
    Dtsch Med Wochenschr; 1982 Apr; 107(14):527-30. PubMed ID: 7040029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The development of wearable-type artificial endocrine pancreas and its usefulness in glycaemic control of human diabetes mellitus.
    Shichiri M; Kawamori R; Hakui N; Asakawa N; Yamasaki Y; Abe H
    Biomed Biochim Acta; 1984; 43(5):561-8. PubMed ID: 6477542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Losartan in diabetic nephropathy.
    Perico N; Ruggenenti P; Remuzzi G
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):473-83. PubMed ID: 15225108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous versus subcutaneous insulin in the postoperative juvenile-onset diabetes mellitus (JODM) patient receiving a renal cadaver transplant.
    Fisher PB; Bennett WM; Norman D; Barry JM
    Proc Clin Dial Transplant Forum; 1980; 10():258-9. PubMed ID: 7050987
    [No Abstract]   [Full Text] [Related]  

  • 31. [The treatment of diabetic nephropathy. The need for an early diagnosis].
    Teruel Briones JL
    Rev Clin Esp; 1999 Jan; 199(1):1-3. PubMed ID: 10089768
    [No Abstract]   [Full Text] [Related]  

  • 32. Polyphenol extracts from Hibiscus sabdariffa Linnaeus attenuate nephropathy in experimental type 1 diabetes.
    Lee WC; Wang CJ; Chen YH; Hsu JD; Cheng SY; Chen HC; Lee HJ
    J Agric Food Chem; 2009 Mar; 57(6):2206-10. PubMed ID: 19219995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The artificial pancreas: how close are we to closing the loop?
    Clarke WL; Kovatchev B
    Pediatr Endocrinol Rev; 2007 Jun; 4(4):314-6. PubMed ID: 17643078
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antihypertensive treatment in type 1 diabetes and diabetic nephropathy].
    Chantrel F; Kolb I; Bouiller M; Hannedouche T
    Nephrologie; 1999; 20(4):203-8. PubMed ID: 10480152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Can diabetic nephropathy be prevented?].
    Viberti GC; Wiseman M; Mackintosch D; Keen H
    Journ Annu Diabetol Hotel Dieu; 1983; ():79-88. PubMed ID: 6358621
    [No Abstract]   [Full Text] [Related]  

  • 36. [Improved metabolic control, kidney function and health care economics are the results of treatment with insulin pump].
    Johansson BL; Berg U; Broberger O; Thalme B
    Lakartidningen; 1983 Oct; 80(41):3818-20. PubMed ID: 6645721
    [No Abstract]   [Full Text] [Related]  

  • 37. Complete remission of diabetic nephropathy in a type 1 diabetic patient with near-nephrotic range proteinuria and reduced renal function.
    Haraguchi K; Hara S; Ubara Y; Tanaka S; Nukui I; Shimura H; Ohashi K; Kobayashi T
    Diabetes Res Clin Pract; 2009 Mar; 83(3):295-9. PubMed ID: 19162360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One year course of oral sulodexide in the management of diabetic nephropathy.
    Achour A; Kacem M; Dibej K; Skhiri H; Bouraoui S; El May M
    J Nephrol; 2005; 18(5):568-74. PubMed ID: 16299683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preprandial and postprandial variations of insulin sensitivity in different times of the day assessed by the artificial pancreas in type I diabetics.
    Trovati M; Bruno A; Lorenzati R; Caselle MT; Pagani A; Gorzegno G; Pagano G
    Chronobiologia; 1981; 8(4):333-40. PubMed ID: 7035094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A type 1 diabetes mellitus patient becomes pregnant. To what do you have to pay attention].
    MMW Fortschr Med; 2002 Oct; 144(41):10. PubMed ID: 12474353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.